Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Pharmaceutical Biology: Top Keynote Speakers You Should Look Out For

Guest Author: Samantha Thorenson

The Top Keynote Speakers You Should Look Out For in the Field of Pharmaceutical Biology

When selecting speakers for an event, it’s important to find those who are knowledgeable about the latest developments in pharmaceutical biology, especially in regards to specific issues or conditions. However, these speakers must also be engaging and offer something of value to their listeners to draw people in to the speaking event. Several speakers have developed a reputation in this field which makes them the top choices for many organizations and special events.

Scott Gottlieb

Dr. Gottlieb is an MD, who has a longstanding career in the field and is recognized as an expert in health policy. He was the FDA Deputy Commissioner for Medical and Science Affairs from 2005 to 2007. He has served in other capacities for the FDA, including as the Senior Advisor for Medical Technology to the Commissioner. He has been asked to give testimony on regulatory issues before both the U.S. Senate and House of Representatives. Articles he has written on health policy have appeared in such prestigious publications as The New York Times and The Wall Street Journal, along with numerous medical journals. Dr. Gottlieb currently serves on several boards, including the Leukemia and Lymphoma Society and the New York University School of Medicine.

John Avellanet

John Avellanet is a businessman, author and entrepreneur in the field of pharmaceutical regulations. He was awarded the title of Best of Business Services from the Small Business Commerce Association in 2009 and 2011. He has developed, implemented and managed multiple compliance systems for the FDA and other organizations. Recently, he was a co-author for the book, Pharmaceutical Regulatory Inspections. He also wrote Get to Market Now! Turn FDA Compliance into a Competitive Ede in the Era of Personalized Medicine. Mr. Avellanet also has an independent consulting and training firm, which is Cerulean Associates LLC.

Richard A. Lindberg

Dr. Lindberg is a Ph.D. and Executive Director and Head for the Centers for Therapeutic Innovation-California at Pfizer. In his position, he is responsible for developing and managing research sites in San Diego and San Francisco and works with universities and other institutions. He works with UCSD, UCSF and Sanford-Burnham Medical Research Institute currently in new collaboration efforts to move basic scientific information into Phase 1 clinical trials. He has been the co-author of more than 70 patents and scientific articles.

Dr. Mao Mao

Dr. Mao Mao is the Research Fellow at Pfizer Oncology Research. In addition, he is the President of Asian Cancer Research Group, Inc. which is a not-for-profit organization that was established by Pfizer, Merch, and Eli Lilly. He coordinated collaborations with various universities and other academic institutions to promote cancer therapy in the Asia Pacific region. In addition to his extensive work in cancer therapy and testing, Dr. Mao Mao has invented over ten patent applications and has had numerous articles published in medical journals. He was also one of the founding members for the National Human Genome Center in Shanghai.

Sources:

http://www.aei.org/scholar/scott-gottlieb/

http://ceruleanllc.com/about/john-avellanet/

http://sabpa.org/html/the-12th-annual-symposium-on-bio-pharmaceuticals-speakers/

SOURCE

From: Samantha Thorenson <samantha@titaniumsuccess.com>

Reply-To: Samantha Thorenson <samantha@titaniumsuccess.com>

Date: Monday, March 14, 2016 at 4:19 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Re: Leaders in Pharmaceutical Business Intelligence